Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells.


Journal

Stem cell reports
ISSN: 2213-6711
Titre abrégé: Stem Cell Reports
Pays: United States
ID NLM: 101611300

Informations de publication

Date de publication:
12 10 2021
Historique:
received: 24 01 2021
revised: 29 08 2021
accepted: 30 08 2021
pubmed: 16 9 2021
medline: 27 10 2021
entrez: 15 9 2021
Statut: ppublish

Résumé

The pathogenicity of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been attributed to its ability to enter through the membrane-bound angiotensin-converting enzyme 2 (ACE2) receptor. Therefore, it has been heavily speculated that angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) therapy may modulate SARS-CoV-2 infection. In this study, exposure of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) and human endothelial cells (hECs) to SARS-CoV-2 identified significant differences in protein coding genes involved in immunity, viral response, and cardiomyocyte/endothelial structure. Specifically, transcriptome changes were identified in the tumor necrosis factor (TNF), interferon α/β, and mitogen-activated protein kinase (MAPK) (hPSC-CMs) as well as nuclear factor kappa-B (NF-κB) (hECs) signaling pathways. However, pre-treatment of hPSC-CMs or hECs with two widely prescribed antihypertensive medications, losartan and lisinopril, did not affect the susceptibility of either cell type to SARS-CoV-2 infection. These findings demonstrate the toxic effects of SARS-CoV-2 in hPSC-CMs/hECs and, taken together with newly emerging multicenter trials, suggest that antihypertensive drug treatment alone does not alter SARS-CoV-2 infection.

Identifiants

pubmed: 34525378
pii: S2213-6711(21)00436-7
doi: 10.1016/j.stemcr.2021.08.018
pmc: PMC8407952
pii:
doi:

Substances chimiques

Antihypertensive Agents 0
Lisinopril E7199S1YWR
Losartan JMS50MPO89

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2459-2472

Subventions

Organisme : NHLBI NIH HHS
ID : F30 HL151139
Pays : United States
Organisme : NHLBI NIH HHS
ID : R00 HL128906
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL123078
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007249
Pays : United States

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Eur J Biochem. 2003 May;270(10):2163-73
pubmed: 12752436
J Korean Med Sci. 2020 Jul 13;35(27):e258
pubmed: 32657091
Front Cell Infect Microbiol. 2021 Jul 06;11:701278
pubmed: 34307198
Am J Physiol Heart Circ Physiol. 2005 Sep;289(3):H1013-9
pubmed: 15833808
J Mol Cell Cardiol. 2002 Jan;34(1):51-62
pubmed: 11812164
N Engl J Med. 2020 Jun 18;382(25):2431-2440
pubmed: 32356627
Circ Res. 2020 Jun 5;126(12):1671-1681
pubmed: 32302265
Nature. 2020 Oct;586(7827):113-119
pubmed: 32707573
Nature. 1980 Nov 20;288(5788):280-3
pubmed: 6253826
Life Sci. 2016 May 15;153:141-52
pubmed: 27085217
J Am Coll Cardiol. 2020 Aug 4;76(5):533-546
pubmed: 32517963
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Nat Commun. 2018 Nov 21;9(1):4906
pubmed: 30464173
JAMA Cardiol. 2021 Jan 1;6(1):116-118
pubmed: 32915194
J Hypertens. 1993 Feb;11(2):155-62
pubmed: 8385175
N Engl J Med. 2020 Jun 18;382(25):2441-2448
pubmed: 32356628
Crit Care. 2020 Jun 16;24(1):353
pubmed: 32546188
Eur Heart J. 2020 May 14;41(19):1798-1800
pubmed: 32186331
Circulation. 2001 Feb 13;103(6):904-12
pubmed: 11171802
Science. 2020 Nov 13;370(6518):856-860
pubmed: 33082293
JAMA Cardiol. 2020 Nov 01;5(11):1265-1273
pubmed: 32730619
J Cardiovasc Pharmacol Ther. 2021 May;26(3):244-252
pubmed: 33231487
Sci Transl Med. 2021 Apr 21;13(590):
pubmed: 33723017
Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
Science. 2020 Feb 21;367(6480):888-892
pubmed: 32079768
Eur Heart J. 2020 May 14;41(19):1804-1806
pubmed: 32293672
Jpn Heart J. 1996 Nov;37(6):905-15
pubmed: 9057685
J Mol Biol. 2006 Mar 31;357(3):964-74
pubmed: 16476442
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W755-62
pubmed: 20513647
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
J Am Coll Cardiol. 2020 Jun 23;75(24):3085-3095
pubmed: 32305401
Lancet. 2020 May 2;395(10234):1417-1418
pubmed: 32325026
Science. 2020 Nov 13;370(6518):861-865
pubmed: 33082294
Eur Rev Med Pharmacol Sci. 2020 May;24(9):5186-5188
pubmed: 32432787
JAMA Intern Med. 2021 Feb 1;181(2):279-281
pubmed: 32986117
Emerg Microbes Infect. 2020 Dec;9(1):757-760
pubmed: 32228222
JACC Basic Transl Sci. 2021 Apr;6(4):331-345
pubmed: 33681537
N Engl J Med. 2020 Jul 30;383(5):496-498
pubmed: 32348640
Heart Rhythm. 2020 Sep;17(9):1463-1471
pubmed: 32387246
Cardiovasc Res. 2020 Dec 1;116(14):2207-2215
pubmed: 32966582
Arterioscler Thromb Vasc Biol. 2015 Jul;35(7):1579-88
pubmed: 25953648
Mediators Inflamm. 2008;2008:305087
pubmed: 19079593
Hypertension. 2004 May;43(5):970-6
pubmed: 15007027
Peptides. 2007 Nov;28(11):2199-210
pubmed: 17904691
J Clin Invest. 1996 Dec 15;98(12):2854-65
pubmed: 8981934
Am J Case Rep. 2020 Jul 01;21:e925554
pubmed: 32606285
Nucleic Acids Res. 2019 May 7;47(8):e47
pubmed: 30783653
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Proc Natl Acad Sci U S A. 2020 Aug 25;117(34):20803-20813
pubmed: 32764148
Stem Cell Reports. 2021 Mar 9;16(3):478-492
pubmed: 33657418
Lancet Respir Med. 2020 Jul;8(7):681-686
pubmed: 32473124
JAMA. 2021 Jan 19;325(3):254-264
pubmed: 33464336
Cell Rep Med. 2020 Jul 21;1(4):100052
pubmed: 32835305
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Circulation. 2001 Jul 10;104(2):191-6
pubmed: 11447085
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
Circulation. 2005 May 24;111(20):2605-10
pubmed: 15897343
Sci China Life Sci. 2020 Mar;63(3):457-460
pubmed: 32009228
Trends Cardiovasc Med. 2003 Apr;13(3):93-101
pubmed: 12691672
Front Med. 2020 Apr;14(2):185-192
pubmed: 32170560
Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1462-8
pubmed: 19666842
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Circulation. 2020 Sep 15;142(11):1123-1125
pubmed: 32689809
Sci Rep. 2018 Nov 1;8(1):16169
pubmed: 30385846
Pflugers Arch. 2001 Sep;442(6):920-7
pubmed: 11680626
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Nature. 2003 Jan 30;421(6922):551-4
pubmed: 12540854
Trends Cardiovasc Med. 2021 Jan;31(1):1-5
pubmed: 33068723

Auteurs

Jessika Iwanski (J)

Department of Cellular and Molecular Medicine and Sarver Heart Center Molecular Cardiovascular Research Program, The University of Arizona, Tucson, AZ, USA.

Sobhi G Kazmouz (SG)

Department of Cellular and Molecular Medicine and Sarver Heart Center Molecular Cardiovascular Research Program, The University of Arizona, Tucson, AZ, USA.

Shuaizhi Li (S)

Department of Immunobiology and the University of Arizona Center on Aging, The University of Arizona, Tucson, AZ, USA.

Ben Stansfield (B)

Department of Cellular and Molecular Medicine and Sarver Heart Center Molecular Cardiovascular Research Program, The University of Arizona, Tucson, AZ, USA; Department of Physiology, The University of Arizona, Tucson, AZ, USA.

Tori T Salem (TT)

Department of Cellular and Molecular Medicine and Sarver Heart Center Molecular Cardiovascular Research Program, The University of Arizona, Tucson, AZ, USA; Department of Physiology, The University of Arizona, Tucson, AZ, USA.

Samantha Perez-Miller (S)

Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.

Toshinobu Kazui (T)

Division of Cardiothoracic Surgery, University of Arizona, Tucson, AZ, USA.

Lipsa Jena (L)

Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.

Jennifer L Uhrlaub (JL)

Department of Immunobiology and the University of Arizona Center on Aging, The University of Arizona, Tucson, AZ, USA.

Scott Lick (S)

Division of Cardiothoracic Surgery, University of Arizona, Tucson, AZ, USA.

Janko Nikolich-Žugich (J)

Department of Immunobiology and the University of Arizona Center on Aging, The University of Arizona, Tucson, AZ, USA; BIO5 Institute, The University of Arizona, Tucson, AZ, USA.

John P Konhilas (JP)

Department of Physiology, The University of Arizona, Tucson, AZ, USA.

Carol C Gregorio (CC)

Department of Cellular and Molecular Medicine and Sarver Heart Center Molecular Cardiovascular Research Program, The University of Arizona, Tucson, AZ, USA.

May Khanna (M)

Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.

Samuel K Campos (SK)

Department of Immunobiology and the University of Arizona Center on Aging, The University of Arizona, Tucson, AZ, USA; Department of Molecular & Cellular Biology, The University of Arizona, Tucson, AZ, USA; Cancer Biology Graduate Interdisciplinary Program, The University of Arizona, Tucson, AZ, USA; BIO5 Institute, The University of Arizona, Tucson, AZ, USA.

Jared M Churko (JM)

Department of Cellular and Molecular Medicine and Sarver Heart Center Molecular Cardiovascular Research Program, The University of Arizona, Tucson, AZ, USA; Department of Physiology, The University of Arizona, Tucson, AZ, USA; BIO5 Institute, The University of Arizona, Tucson, AZ, USA. Electronic address: jchurko@arizona.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH